The Effectiveness of Squat Exercise for Improving Pre-Sarcopenia in Order Adults

NCT07726758 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-07-24

No results posted yet for this study

Summary

With the growing aging population, it has been reported that approximately 10-20% of older adults have pre-sarcopenia. Pre-sarcopenia is defined as a decline in either muscle mass or muscle strength. Previous studies have indicated that squat exercise has significant effects on improving lower-extremity muscle strength and physical performance. Early intervention through resistance exercise during the pre-sarcopenia stage may increase muscle mass, enhance physical performance, and prevent progression to sarcopenia. Therefore, the purpose of this study is to investigate the effects of squat exercise on improving pre-sarcopenia among older adults. It is expected that, following the squat exercise intervention, older adults will demonstrate significant improvements in muscle mass, lower-extremity muscle strength, physical performance, and body composition, thereby alleviating pre-sarcopenia.

Conditions

Interventions

BEHAVIORAL

Squat Exercise

Squat exercise is an effective resistance training intervention that enhances lower-extremity muscle strength, physical performance, and functional ability, thereby helping prevent or delay sarcopenia in older adults.

Sponsors & Collaborators

  • Tzu Chi University

    lead OTHER

Principal Investigators

  • HSIAO-CHIEN TSENG, MASTER · STUDENT

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
SEQUENTIAL

Eligibility

Min Age
65 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-06
Primary Completion
2026-12-31
Completion
2028-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07726758 on ClinicalTrials.gov